Immunic Appoints Michael Panzara as Chief Medical Officer
Immunic announced the appointment of Michael Panzara as chief medical officer, effective April 24. Panzara will lead the company's development organization, including clinical development, medical affairs, and regulatory affairs, and will be a partner to the CEO and the board of directors in defining and driving the overall company strategy. Panzara succeeds Andreas Muehler. Panzara most recently served as chief medical officer of Neurvati Neurosciences.
